Adolescents exposed to violence or terror attacks have an increased risk for daily and weekly migraine and tension-type headache following the event.
Compare the abuse deterrent mechanism, special risk groups, contraindications, and warnings/precautions for FDA approved opioids.
ASRA released a formal position statement requesting that the DEA reschedule marijuana.
Patients with a history of abuse either in childhood or adulthood have been found to display higher levels of depression, anxiety, pain severity and catastrophizing, as well as reduced physical functioning; in addition, those patients have higher scores on the fibromyalgia survey used to measure "fibromyalgia-ness" than those without a history of abuse.
Several patients were noted to have taken the counterfeit drug in California.
Combination of a motivational interviewing and enhanced brochures successful in reducing behaviors associated with opioid overdose.
Preoperative opioid use is a better predictor for prolonged postoperative opioid use than pain, substance abuse, and affective disorder.
New research suggests that reducing length of treatment and hospitalization in infants diagnosed with drug withdrawal symptoms at birth can be made possible by standardizing hospital care policies across institutions.
Craving is known to be influenced by patient-specific variables such as sex, negative affect, and history of SUD,but few studies have examined the impact of day-to-day changes in pain intensity.
The ASA has announced the creation of its Ad Hoc Committee on Prescription Opioid Abuse to help address the country's growing epidemic.
Military Medical School Addresses Opioid Epidemic by Incorporating Joint Pain Education Into CurriculumMarch 30, 2016
The F. Edward Hebert School of Medicine at the USU this week announced the addition of a new pain management program that incorporates joint pain education into its curriculum
President Barack Obama will announce new public and private initiatives directed at curbing opioid abuse across the country.
Researchers found the importance of intense behavioral health follow-up to reduce the occurrence of neonatal abstinence syndrome.
While 99% exceed the recommended 3-day dosage limit, a quarter write a prescription for a full month.
Many do not tell their doctors, putting them at risk for dangerous drug interactions.
New labeling rules mostly aimed at immediate-release versions of opioids.
Mainly supportive of guidelines, but concerns include lack of evidence underlying recommendations.
New research reviews nationwide patterns of painkiller prescribing following surgical tooth extraction.
The CDC has issued guidelines for primary care providers who prescribe opioids for chronic pain.
CMS suppression of claims linked to immediate decline in inpatient rates of related comorbidities.
To understand patterns of postoperative opioid prescribing over time, researchers examined the trends of commonly-prescribed opioids after low-risk surgical procedures in the United States.
Does your pain clinic currently allow the use of cannabis in combination with opioid medication? If so, has a maximum THC threshold been identified? How have your patients responded to such treatment?
Are we overestimating the efficacy of step III analgesics?
Patient monitoring and pain specialist support can help primary care practitioners better manage their patients taking opioids for chronic pain.
Much of the third world is suffering in pain without access to opioids. This imbalance has been called the opioid gap. How can we get opioids to patients who need them?
Understanding factors that influence medication nonadherence may guide clinicians in implementing adherence strategies.
Clinicians are doing their fair share of curbing opioid-related deaths in the country. They just need to amplify their efforts a little more by changing the narrative.
Clinical Pain Advisor met up with Dr Erin E Krebs at AAPM's annual meeting after her discussion on what opioids mean for the primary care physician in 2016 to discuss the CDC's guidelines for prescribing opioids in patients with chronic pain.
The FDA has announced a new plan to refocus its efforts on curbing opioid-related deaths.
New research assesses initiatives to reduce high-dose COT prescribing.
Clinical Pain Advisor Articles
- Cannabis Use High in Migraine
- Sustained-Release Sodium Nitrite for Diabetic Neuropathic Pain Not Associated With Headaches
- Restless Leg Syndrome, Fibromyalgia, and Depression Frequent in Migraine
- Percutaneous Electrolysis May Be Useful Adjunct for Subacromial Pain Syndrome
- Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths
- Recommendations for Perioperative Pain Management in Patients With Opioid Tolerance
- Vertebroplasty Comparable With Placebo for Acute Vertebral Compression Fractures
- Capsaicin 8% Patch May Be Effective in Neuropathic Pain
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Prior Authorization Policy May Help Reduce Long-Acting Opioid Use
- Deaths After Nonfatal Opioid Overdose: Causes and Risk Factors
- Targeted Educational Intervention Helped Reduce Opioid Exposure in Adult Inpatients
- Systematic Cross-Checking May Reduce Medical Errors in Emergency Departments
- Corticosteroid Plus Lidocaine Injections Do Not Alleviate Pain in Central Lumbar Spinal Stenosis
- Tofacitinib May Effectively Alleviate Pain in RA, Psoriatic Arthritis, and Ankylosing Spondylitis